Opening New Doors Llc - Medicare Mental Health Clinic in Grosse Pointe, MI

Opening New Doors Llc is a medicare enrolled mental health clinic (Counselor - Mental Health) in Grosse Pointe, Michigan. The current practice location for Opening New Doors Llc is 17844 Mack Ave, Grosse Pointe, Michigan. For appointments, you can reach them via phone at (248) 417-0248. The mailing address for Opening New Doors Llc is 17844 Mack Ave, Grosse Pointe, Michigan and phone number is (248) 417-0248.

Opening New Doors Llc is licensed to practice in * (Not Available) (license number ). The clinic also participates in the medicare program and its NPI number is 1144936626. This medical practice accepts medicare insurance (which means this clinic accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance). However, please confirm if they accept your insurance at (248) 417-0248.

Contact Information

Opening New Doors Llc
17844 Mack Ave
Grosse Pointe
MI 48230-6234
(248) 417-0248
Not Available

Mental Health Clinic Profile

Full NameOpening New Doors Llc
SpecialityCounselor
Location17844 Mack Ave, Grosse Pointe, Michigan
Authorized Official Name and PositionNeoshua Butler (CLINICAL DIRECTOR)
Authorized Official Contact2484170248
Accepts Medicare InsuranceYes. This clinic participates in medicare program and accept medicare insurance.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Opening New Doors Llc
17844 Mack Ave
Grosse Pointe
MI 48230-6234

Ph: (248) 417-0248
Opening New Doors Llc
17844 Mack Ave
Grosse Pointe
MI 48230-6234

Ph: (248) 417-0248

NPI Details:

NPI Number1144936626
Provider Enumeration Date01/27/2023
Last Update Date05/09/2023
Certification Date05/09/2023

Medicare PECOS Information:

Medicare PECOS PAC ID2668831066
Medicare Enrollment IDO20230703001497

News Archive

Matrix Laboratories receives FDA tentative approval for Efavirenz NDA under PEPFAR

Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited has received tentative approval from the U.S. Food and Drug Administration (FDA) under the President's Emergency Plan for AIDS Relief (PEPFAR) for its New Drug Application (NDA) for Efavirenz Tablets, 50 mg, 100 mg and 200 mg. These innovative pediatric dosages in tablet form were developed by Matrix for use in treating pediatric HIV/AIDS.

FDA clears expanded indications for InTouch Health Remote Presence devices

InTouch Health, the world's premier provider of acute care telemedicine solutions, has received a new Food and Drug Administration (FDA) 510(k) clearance with expanded indications for use for its range of Remote Presence devices which includes RP-7i®, RP-Lite®, RP-Vantage® and RP-Xpress® as well as VisitOR1® which is sold by and is a registered trademark of Karl Storz.

Therakos introduces Lighting Up Lives campaign for patients with immune diseases

Therakos, Inc., a pioneer in the development of an innovative immune modulation therapy called extracorporeal photopheresis (ECP), today launched Lighting Up Lives, a 25-year anniversary campaign and year-long global initiative that honours the lives of patients with serious immune diseases impacted by ECP, as well as the healthcare professionals, caregivers and treatment centres that support them every step of the way.

Zynex third quarter net revenues increase 42% to $6,657,000

Zynex, Inc., a provider of pain management systems and electrotherapy products for medical patients with functional disability, announces a record number of orders and billed patients in the three months ended September 30, 2010. The Company also generated record net revenues of $6,657,000 for the three months ended September 30, 2010, which represents a 42% increase over third quarter 2009 net revenue and a 16% increase sequentially over the second quarter of 2010.

Mother's miracle surgery for cancer - body cut in half

Janis Ollson, 31 became the first patient to survive a rare bone cancer which required her body to be cut in half. When she was pregnant with her second child doctors assumed her intense back pain was just a typical symptom of pregnancy. But soon she was diagnosed with a bone cancer called sarcoma that was untreatable by chemotherapy or radiation.

Read more Medical News

› Verified 2 days ago

Medical Identifiers

Medical identifiers for Opening New Doors Llc such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1144936626NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
101YM0800XCounselor - Mental Health (* (Not Available))Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Opening New Doors Llc acts as a billing entity for following providers:
Provider NameNeoshua Butler
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1699289918
PECOS PAC ID: 5395104798
Enrollment ID: I20230703001636

News Archive

Matrix Laboratories receives FDA tentative approval for Efavirenz NDA under PEPFAR

Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited has received tentative approval from the U.S. Food and Drug Administration (FDA) under the President's Emergency Plan for AIDS Relief (PEPFAR) for its New Drug Application (NDA) for Efavirenz Tablets, 50 mg, 100 mg and 200 mg. These innovative pediatric dosages in tablet form were developed by Matrix for use in treating pediatric HIV/AIDS.

FDA clears expanded indications for InTouch Health Remote Presence devices

InTouch Health, the world's premier provider of acute care telemedicine solutions, has received a new Food and Drug Administration (FDA) 510(k) clearance with expanded indications for use for its range of Remote Presence devices which includes RP-7i®, RP-Lite®, RP-Vantage® and RP-Xpress® as well as VisitOR1® which is sold by and is a registered trademark of Karl Storz.

Therakos introduces Lighting Up Lives campaign for patients with immune diseases

Therakos, Inc., a pioneer in the development of an innovative immune modulation therapy called extracorporeal photopheresis (ECP), today launched Lighting Up Lives, a 25-year anniversary campaign and year-long global initiative that honours the lives of patients with serious immune diseases impacted by ECP, as well as the healthcare professionals, caregivers and treatment centres that support them every step of the way.

Zynex third quarter net revenues increase 42% to $6,657,000

Zynex, Inc., a provider of pain management systems and electrotherapy products for medical patients with functional disability, announces a record number of orders and billed patients in the three months ended September 30, 2010. The Company also generated record net revenues of $6,657,000 for the three months ended September 30, 2010, which represents a 42% increase over third quarter 2009 net revenue and a 16% increase sequentially over the second quarter of 2010.

Mother's miracle surgery for cancer - body cut in half

Janis Ollson, 31 became the first patient to survive a rare bone cancer which required her body to be cut in half. When she was pregnant with her second child doctors assumed her intense back pain was just a typical symptom of pregnancy. But soon she was diagnosed with a bone cancer called sarcoma that was untreatable by chemotherapy or radiation.

Read more Medical News

› Verified 2 days ago

News Archive

Matrix Laboratories receives FDA tentative approval for Efavirenz NDA under PEPFAR

Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited has received tentative approval from the U.S. Food and Drug Administration (FDA) under the President's Emergency Plan for AIDS Relief (PEPFAR) for its New Drug Application (NDA) for Efavirenz Tablets, 50 mg, 100 mg and 200 mg. These innovative pediatric dosages in tablet form were developed by Matrix for use in treating pediatric HIV/AIDS.

FDA clears expanded indications for InTouch Health Remote Presence devices

InTouch Health, the world's premier provider of acute care telemedicine solutions, has received a new Food and Drug Administration (FDA) 510(k) clearance with expanded indications for use for its range of Remote Presence devices which includes RP-7i®, RP-Lite®, RP-Vantage® and RP-Xpress® as well as VisitOR1® which is sold by and is a registered trademark of Karl Storz.

Therakos introduces Lighting Up Lives campaign for patients with immune diseases

Therakos, Inc., a pioneer in the development of an innovative immune modulation therapy called extracorporeal photopheresis (ECP), today launched Lighting Up Lives, a 25-year anniversary campaign and year-long global initiative that honours the lives of patients with serious immune diseases impacted by ECP, as well as the healthcare professionals, caregivers and treatment centres that support them every step of the way.

Zynex third quarter net revenues increase 42% to $6,657,000

Zynex, Inc., a provider of pain management systems and electrotherapy products for medical patients with functional disability, announces a record number of orders and billed patients in the three months ended September 30, 2010. The Company also generated record net revenues of $6,657,000 for the three months ended September 30, 2010, which represents a 42% increase over third quarter 2009 net revenue and a 16% increase sequentially over the second quarter of 2010.

Mother's miracle surgery for cancer - body cut in half

Janis Ollson, 31 became the first patient to survive a rare bone cancer which required her body to be cut in half. When she was pregnant with her second child doctors assumed her intense back pain was just a typical symptom of pregnancy. But soon she was diagnosed with a bone cancer called sarcoma that was untreatable by chemotherapy or radiation.

Read more News

› Verified 2 days ago

Counselor in Grosse Pointe, MI

Innovative Psychological Services Llc
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 377 Fisher Rd Ste D3, Grosse Pointe, MI 48230
Phone: 248-537-2489    
Karen Webb Acsw Pc
Mental Health Clinic
Medicare: Medicare Enrolled
Practice Location: 18090 Mack Ave, Suite B, Grosse Pointe, MI 48230
Phone: 313-642-1997    Fax: 313-642-1998
Dr. Robin Ramsay, Ph.d, Lp, Plc
Mental Health Clinic
Medicare: Medicare Enrolled
Practice Location: 18090 Mack Ave, Grosse Pointe, MI 48230
Phone: 313-702-0062    Fax: 313-642-1998
Scheerbert Psychological, Pllc
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 18090 Mack Ave, Suite 4, Grosse Pointe, MI 48230
Phone: 248-415-4471    
C. Miles Sterling Psy.d. Pc
Mental Health Clinic
Medicare: Medicare Enrolled
Practice Location: 702 Notre Dame St, Ste 101, Grosse Pointe, MI 48230
Phone: 313-343-6470    
Peggy Woehrlen Acsw Lmsw Lmft Pc
Mental Health Clinic
Medicare: Medicare Enrolled
Practice Location: 18090 Mack Ave, Grosse Pointe, MI 48230
Phone: 248-701-4977    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.